<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2301-0371</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Enfermería (En línea)]]></journal-title>
<abbrev-journal-title><![CDATA[Revista urug. enferm. (En línea)]]></abbrev-journal-title>
<issn>2301-0371</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Enfermería de la Universidad de la República]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2301-03712024000101203</article-id>
<article-id pub-id-type="doi">https://doi.org/10.33517/rue2024v19n1a3</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Percepción y conocimiento de Diabetes tipo 2 y riesgo de diabesidad en adultos.]]></article-title>
<article-title xml:lang="en"><![CDATA[Perception and knowledge of type 2 Diabetes and diabesity risk in adults.]]></article-title>
<article-title xml:lang="pt"><![CDATA[Percepção e conhecimento do risco de Diabetes tipo 2 e diabetes em adultos.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[de-la-Vega]]></surname>
<given-names><![CDATA[Dannya]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramirez-Giron]]></surname>
<given-names><![CDATA[Natalia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Fundación Universidad de las Américas Puebla PESS CS3NB Almecatla ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Fundación Universidad de las Américas Puebla  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>19</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2301-03712024000101203&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2301-03712024000101203&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2301-03712024000101203&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  Las enfermedades crónicas no transmisibles se han convertido en un problema mundial debido a los altos índices de morbilidad y mortalidad, derivadas de estilos de vida inadecuados que incluyen una falta de una percepción y bajo conocimiento de estos padecimientos.  Objetivo:  Establecer la relación entre la percepción y el conocimiento de Diabetes Tipo 2 y el Riesgo de Diabesidad en adultos de Puebla.  Metodología:  Cuantitativo con diseño descriptivo, correlacional y de alcance transversal, se incluyeron personas de 20 a 65 pertenecientes al Centro de Salud de Almecatla, Puebla. Se excluyeron a las personas que hablen lengua indígena y mujeres embarazadas. El cálculo de la muestra fue de 182 personas. Se utilizó el instrumento DKQ-24 y Percepción de Riesgo de Diabetes, una cédula de datos socio demográfica y consentimiento informado.  Análisis y resultados  El 78% fueron mujeres, con promedio de edad de 58.8 años, glicemia capilar 163.8, hemoglobina glucosilada 8.6, 88.5% tienen conocimiento de DT2 adecuado y el 50.5% una percepción de riesgo de DT2 alto. Existe una relación positiva y significativa entre el conocimiento y la percepción de riesgo de DT2 (p&lt;.05).  Conclusión:  Existe una correlación positiva significativa entre el conocimiento de DT2 y la percepción de riesgo de DT2. Existen indicadores corporales y bioquímicos que sugieren el aumento del riesgo de Diabesidad, a pesar de la asistencia al centro de salud no se refleja el control de las patologías, por tal motivo persisten los niveles de morbi-mortalidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Chronic non-communicable diseases have become a global problem due to high morbidity and mortality rates, derived from inadequate lifestyles that include a lack of perception and low knowledge of these conditions.  Objective:  To stablish the relation between perception and knowledge of Type 2 Diabetes and the Risk of Diabesity in adults from Puebla.  Method:  Quantitative with a descriptive, correlational and cross-sectional design, including people from 20 to 65 belonging to the Almecatla Health Center, Puebla. People who spoke an indigenous language and pregnant women were excluded. The calculation of the sample was 182 people. The DKQ-24 instrument and Diabetes Risk Perception, a socio-demographic data card and informed consent were acquired.  Analysis and results:  78% were women, with an average age of 58.8 years, capillary glycemia 163.8, glycosylated hemoglobin 8.6, 88.5% have adequate knowledge of T2D and 50.5% a perception of high T2D risk. There is a positive and significant relationship between knowledge and perception of T2D risk (p&lt;.05).  Conclusion:  There is a significant positive correlation between the knowledge of T2D and the perception of T2D risk. There are bodily and biochemical indicators that suggest the increased risk of Diabesity, despite the attendance at the health center, the control of the pathologies is not reflected, for this reason the levels of morbidity and mortality persist.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  As doenças crônicas não transmissíveis tornaram-se um problema global devidoàs altas taxas de morbidade e mortalidade, decorrentes de estilos de vida inadequados que incluem a falta de percepção e baixo conhecimento dessas condições.  Objetivo:  Estabelecer a relação entre percepção e conhecimento sobre Diabetes Tipo 2 e Risco de Diabesidade em adultos de Puebla.  Método:  Quantitativa com desenho descritivo, correlacional e transversal, incluindo pessoas de 20 a 65 anos pertencentes ao Centro de Saúde Almecatla, Puebla. Foram excluídas pessoas que falam línguas indígenas e gestantes. O cálculo a mostra foi de 182 pessoas. Foram utilizados o instrumento DKQ-24 e Percepção de Risco de Diabetes, ficha de dados sociodemográficos e consentimento informado.  Análise e resultados:  78% eran mulheres, com idade média de 58,8 anos, glicemia capilar 163,8, hemoglobina glicosilada 8,6, 88,5% têm conhecimento adequado de DM2 e 50,5% percepção de alto risco de DM2. Existe uma relação positiva e significativa entre o conhecimento e a percepção do risco de DM2 (p&lt;0,05).  Conclusão:  Existe uma correlação positiva significativa entre o conhecimento de DM2 e a percepção do risco de DM2. Existem indicadores corporais e bioquímicos que sugerem o aumento do risco de Diabesidade, apesar da ida ao centro de saúde não se reflectir no controlo das patologias, por isso persistem os níveis de morbilidade e mortalidade.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Diabetes Mellitus Tipo 2]]></kwd>
<kwd lng="es"><![CDATA[Obesidad]]></kwd>
<kwd lng="es"><![CDATA[Adulto]]></kwd>
<kwd lng="es"><![CDATA[México]]></kwd>
<kwd lng="en"><![CDATA[Diabetes Mellitus Type 2]]></kwd>
<kwd lng="en"><![CDATA[Obesity]]></kwd>
<kwd lng="en"><![CDATA[Adult]]></kwd>
<kwd lng="en"><![CDATA[México]]></kwd>
<kwd lng="pt"><![CDATA[Diabetes Mellitus Tipo 2]]></kwd>
<kwd lng="pt"><![CDATA[Obesidade]]></kwd>
<kwd lng="pt"><![CDATA[Adulto]]></kwd>
<kwd lng="pt"><![CDATA[México]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1-</label><nlm-citation citation-type="">
<source><![CDATA[Now diabetes by heart.]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mendoza Romo]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Padrón Salas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cossío Torres]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Soria Orozco]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia mundial de la diabetes mellitus tipo 2 y su relación con el índice de desarrollo humano.]]></article-title>
<source><![CDATA[RevPanam Salud Pública]]></source>
<year>2017</year>
<volume>41</volume>
</nlm-citation>
</ref>
<ref id="B3">
<label>3-</label><nlm-citation citation-type="">
<source><![CDATA[Encuesta Nacional de Salud y Nutrición.]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4-</label><nlm-citation citation-type="">
<source><![CDATA[En México, 12.4 millones de personas viven con diabetes.]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5-</label><nlm-citation citation-type="">
<source><![CDATA[Obesidad y sobrepeso]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6-</label><nlm-citation citation-type="">
<source><![CDATA[Diagnóstico y tratamiento de dislipidemias (hipercolesterolemia) en adultos.]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7-</label><nlm-citation citation-type="">
<source><![CDATA[Diagnóstico y tratamiento de hipertensión arterial en el adulto mayor.]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8-</label><nlm-citation citation-type="">
<source><![CDATA[Prevención, diagnóstico y tratamiento del sobrepeso y la obesidad exógena.]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9-</label><nlm-citation citation-type="">
<source><![CDATA[Indicadores de sobrepeso y obesidad. Secretaria de Salud.]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Farzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fröhlich]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Holzer]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gut microbiota and the neuroendocrine system neurotherapeutics.]]></article-title>
<source><![CDATA[Neurotherapeutics]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11-</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alarcón]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Niechi]]></surname>
<given-names><![CDATA[I,]]></given-names>
</name>
<name>
<given-names><![CDATA[ToledoF]]></given-names>
</name>
<name>
<surname><![CDATA[Sobrevia L]]></surname>
<given-names><![CDATA[Quezada C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Glioma progression in diabesity. Molecular aspectsof medicine]]></source>
<year>2019</year>
<volume>66</volume>
<page-range>62-70</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toplak]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Leitner]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Harreiter]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hoppichler]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Wascher]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Schindler]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabesity-Obesity and type 2 diabetes.]]></article-title>
<source><![CDATA[Wiener KlinischeWochenschrift]]></source>
<year>2019</year>
<volume>131</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>71-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tuttle]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bittel]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Bittel]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sinacore]]></surname>
<given-names><![CDATA[DR.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early-Onset physical frailty in adults with diabesity and peripheral neuropathy]]></article-title>
<source><![CDATA[Canadian Journal of Diabetes]]></source>
<year>2018</year>
<volume>42</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>478-83</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wells]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The diabesity epidemic in the light of evolution: insights from the capacity-load model.]]></article-title>
<source><![CDATA[Diabetologia]]></source>
<year>2019</year>
<volume>62</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1740-50</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de-la-Vega]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Morquecho-Nava]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Isidro-Pérez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Girón]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis del concepto "Diabesidad".]]></article-title>
<source><![CDATA[IndexEnferm]]></source>
<year>2022</year>
<volume>31</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>289-93</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meenu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A critical review on anti-diabetic and anti-obesity effects of dietary resistant starch.]]></article-title>
<source><![CDATA[Crit Rev Food SciNutr]]></source>
<year>2018</year>
<volume>59</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>3019-31</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colagiuri]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabesity: therapeutic options.]]></article-title>
<source><![CDATA[Diabetes, obesity and metabolism]]></source>
<year>2010</year>
<volume>12</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>463-73</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Collino]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Benetti]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rogazzo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mastrocola]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Yaqoob]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Aragno]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-dagonism correlates with impaired NLRP3 inflammasome activation.]]></article-title>
<source><![CDATA[Biochemicalpharmacology]]></source>
<year>2013</year>
<volume>85</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>257-64</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19-</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[American Medical Association]]></article-title>
<source><![CDATA[Conocimientos básicos sobre salud]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20-</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Commodaria]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[La Rosa]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
<name>
<surname><![CDATA[Conigilio]]></surname>
<given-names><![CDATA[MA.]]></given-names>
</name>
</person-group>
<source><![CDATA[Percepciones de riesgo para la salud en la era del nuevo coronavirus.]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lesmes C]]></surname>
<given-names><![CDATA[MartínezM]]></given-names>
</name>
<name>
<surname><![CDATA[Montoya G]]></surname>
<given-names><![CDATA[Rodríguez L]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez A]]></surname>
<given-names><![CDATA[SbaiS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percepción de las personas con diabetes mellitus tipo 2 de su calidad de vida.]]></article-title>
<source><![CDATA[FarmComunitarios]]></source>
<year>2020</year>
<volume>12</volume>
<numero>^sSupl 2. Congreso SEFAC 2020</numero>
<issue>^sSupl 2. Congreso SEFAC 2020</issue>
<supplement>Supl 2. Congreso SEFAC 2020</supplement>
</nlm-citation>
</ref>
<ref id="B22">
<label>22-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uribe-CarvajalR]]></surname>
<given-names><![CDATA[Jiménez-Aguilar A]]></given-names>
</name>
<name>
<surname><![CDATA[Morales-Ruan M]]></surname>
<given-names><![CDATA[Salazar-Coronel A]]></given-names>
</name>
<name>
<surname><![CDATA[Shamah-Levy T.]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percepción del peso corporal y la probabilidad de desarrollar obesidad en adultos mexicanos.]]></article-title>
<source><![CDATA[Salud pública Méx]]></source>
<year>2018</year>
<volume>60</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>254-62</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galindo Gómez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Juárez Martínez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Shamah Levy]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[García Guerra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ávila Curiel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Quiroz Aguilar]]></surname>
<given-names><![CDATA[MA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conocimientos en nutrición, sobrepeso u obesidad en mujeres de estratos socioeconómicos bajos de la Ciudad de México]]></article-title>
<source><![CDATA[ALAN]]></source>
<year>2011</year>
<volume>61</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>396-405</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García AA]]></surname>
<given-names><![CDATA[Villagomez ET]]></given-names>
</name>
<name>
<surname><![CDATA[Brown SA]]></surname>
<given-names><![CDATA[Kouzekanani K]]></given-names>
</name>
<name>
<surname><![CDATA[HanisCL.]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The starrcountry diabetes education study: development of the spanish-lenguage diabetes knowledge questionnaire.]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2001</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>16-21</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez-Encino]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz-León]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata-Vázquez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Morales- Ramón]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nivel de conocimiento que tienen los pacientes con Diabetes Mellitus tipo 2 en relación a su enfermedad.]]></article-title>
<source><![CDATA[Salud en Tabasco]]></source>
<year>2015</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-25</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[VD]]></given-names>
</name>
<name>
<surname><![CDATA[Ryan-Wenger]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Driessnack]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jaber]]></surname>
<given-names><![CDATA[AF.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factorial structure of the perception of risk factors for type 2 diabetes scale: exploratory and confirmatory factor analyses]]></article-title>
<source><![CDATA[J EvalClinPract]]></source>
<year>2010</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1096-102</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27-</label><nlm-citation citation-type="">
<source><![CDATA[Encuesta Nacional de Salud y Nutrición 2018 resultados Puebla.]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B28">
<label>28-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pavón de Paz]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Alameda Hernando]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Olivar Roldán]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesidad y menopausia.]]></article-title>
<source><![CDATA[Nutr. Hosp]]></source>
<year>2006</year>
<volume>21</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>633-7</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pappachan]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandez]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chacko]]></surname>
<given-names><![CDATA[EC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabesity and antidiabetic drugs.]]></article-title>
<source><![CDATA[Mol Aspects Med]]></source>
<year>2019</year>
<volume>66</volume>
<page-range>3-12</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30-</label><nlm-citation citation-type="">
<source><![CDATA[Norma Oficial Mexicana NOM-008-SSA3-2010 para el tratamiento integral del sobrepeso y la obesidad.]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B31">
<label>31-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Rajpal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Upadhyay]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Shaha]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Deo]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Status of diabetes control and knowledgeabout diabetes in patients.]]></article-title>
<source><![CDATA[Endocrinol Diabetes Nutr. Engl Ed]]></source>
<year>2021</year>
</nlm-citation>
</ref>
<ref id="B32">
<label>32-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casanova]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nivel de conocimiento sobre diabetes mellitus que tienen los pacientes diagnosticados del servicio médico Sanitas de Venezuela entre diciembre 2015 a julio 2016.]]></article-title>
<source><![CDATA[Revista Diabetes (Venezuela).]]></source>
<year>2017</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B33">
<label>33-</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vera-Ponce]]></surname>
<given-names><![CDATA[VJ]]></given-names>
</name>
<name>
<surname><![CDATA[Talavera]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Malca]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[De-La-Cruz-Vargas]]></surname>
<given-names><![CDATA[JA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Combinaciones de síndrome metabólico y riesgo de diabetes mellitus.]]></article-title>
<source><![CDATA[Revista Cubana de Medicina Militar]]></source>
<year>2022</year>
<volume>51</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
